Cambridge Investment Research Advisors’s Redhill Biopharma RDHL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-26	Closed	-$65K	–	3179
2022 Q1	$65K	Sell	26 -2	-7%	-$5K	﹤0.01%	3062
2021 Q4	$71K	Buy	+28	New	+$71K	﹤0.01%	3068